18551349. INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING simplified abstract (The General Hospital Corporation)
Contents
- 1 INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Unanswered Questions
- 1.11 Original Abstract Submitted
INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING
Organization Name
The General Hospital Corporation
Inventor(s)
Ying Wang of Winchester MA (US)
R. Rox Anderson of Boston MA (US)
William Farinelli of Danvers MA (US)
INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING - A simplified explanation of the abstract
This abstract first appeared for US patent application 18551349 titled 'INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING
Simplified Explanation
The abstract describes a system and method for providing an autologous bio-filler to a patient by harvesting dermal columns, mincing them into microsegments, and injecting them into a recipient site.
- Harvesting dermal columns from a harvesting site
- Mincing dermal columns into microsegments
- Forming microsegments into an autologous bio-filler
- Injecting the autologous bio-filler into a recipient site of the patient
Potential Applications
This technology could be used in cosmetic procedures, reconstructive surgery, and regenerative medicine.
Problems Solved
This technology provides a natural and personalized solution for soft tissue augmentation, reducing the risk of rejection or adverse reactions.
Benefits
The use of autologous bio-fillers can lead to improved aesthetic outcomes, reduced complications, and increased patient satisfaction.
Potential Commercial Applications
"Autologous Bio-Filler Technology: Revolutionizing Soft Tissue Augmentation"
Possible Prior Art
There are existing methods for soft tissue augmentation using synthetic fillers, but the use of autologous bio-fillers offers a more natural and personalized approach.
Unanswered Questions
How long does the procedure take from harvesting to injection?
The abstract does not provide information on the timeline of the procedure, including the time required for harvesting, processing, and injecting the autologous bio-filler.
What are the potential side effects or complications associated with this technology?
The abstract does not mention any potential risks or complications that may arise from using autologous bio-fillers for soft tissue augmentation.
Original Abstract Submitted
A system and method for providing an autologous bio-filler to a patient is provided. The method includes harvesting dermal columns from a harvesting site and mincing the dermal columns into microsegments, where the microsegments form the autologous bio-filler. The method also includes injecting the autologous bio-filler into a recipient site of the patient.
